Vitro Diagnostics, Inc., doing business as Vitro Biopharma, focuses on the development, manufacture, and distribution of stem cell products and related tools for use in research, drug discovery, and clinical trials in the United States. Its stem cell technology includes cell lines, supporting products, and methods for generation and differentiation of stem cells into products for the treatment of diseases, such as heart disease, arthritis, multiple sclerosis, brain injury, autism, stroke, Parkinson's, and Alzheimer's diseases. The company also offers Tools for Stem Cell and Drug Discovery that provide researchers basic tools needed to advance stem cell technology, including stem cells and their derivatives; media for growth and differentiation of stem cells; and tools for measurement of stem cell quality, potency, and response to toxic agents. In addition, it offers MSC-Gro, a cell culture media product; MSC cell line for the treatment of skeletal muscular conditions, such as tendonitis, ligament injury, osteoarthritis and accelerated bone fracture healing, etc.; and testing and therapies related to endogenous stem cell activation. Further, the company provides diagnostic testing of stem cell activation and determination of stem cell functional status; and cell-based assays for discovery of novel stem cell activation agents and drugs for the treatment of osteoporosis. Vitro Diagnostics, Inc. was founded in 1986 and is based in Golden, Colorado.
Industry, Sector and Symbol
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Phone303-999-2130
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Vitro Diagnostics (OTCMKTS:VODG) Frequently Asked Questions
What is Vitro Diagnostics' stock symbol?
Vitro Diagnostics trades on the OTCMKTS under the ticker symbol "VODG."
Has Vitro Diagnostics been receiving favorable news coverage?
News headlines about VODG stock have trended somewhat negative on Saturday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Vitro Diagnostics earned a news sentiment score of -1.5 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Vitro Diagnostics.
Who are some of Vitro Diagnostics' key competitors?
Some companies that are related to Vitro Diagnostics include Microbot Medical (MBOT), Vical (VICL), aTyr Pharma (LIFE), Enzon Pharmaceuticals (ENZN), CytRx (CYTR), TRACON Pharmaceuticals (TCON), Genetic Technologies (GENE), Aevi Genomic Medicine (GNMX), TrovaGene (TROV), Titan Pharmaceuticals (TTNP), Vaxart (VXRT), Proteon Therapeutics (PRTO), Neuralstem (CUR), Gene Biotherapeutics (CRXM) and AIM ImmunoTech (AIM).
What other stocks do shareholders of Vitro Diagnostics own?
Who are Vitro Diagnostics' key executives?
Vitro Diagnostics' management team includes the folowing people:
- Dr. James R. Musick, Chairman, CEO & Pres (Age 72)
- Mr. John R. Evans, CFO & Director (Age 64)
- Mr. Keith V. Burge, Sr. Director of Sales & Marketing
How do I buy shares of Vitro Diagnostics?
Shares of VODG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Vitro Diagnostics' stock price today?
One share of VODG stock can currently be purchased for approximately $0.23.
How big of a company is Vitro Diagnostics?
What is Vitro Diagnostics' official website?
How can I contact Vitro Diagnostics?
Vitro Diagnostics' mailing address is 4621 Technology Drive, Golden CO, 80403. The company can be reached via phone at 303-999-2130 or via email at [email protected]
MarketBeat Community Rating for Vitro Diagnostics (OTCMKTS VODG)
MarketBeat's community ratings are surveys of what our community members think about Vitro Diagnostics and other stocks. Vote "Outperform" if you believe VODG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VODG will underperform the S&P 500 over the long term. You may vote once every thirty days.
